International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(2), С. 1228 - 1228
Опубликована: Янв. 19, 2024
The
intestinal
microbiota
is
a
community
of
microorganisms
inhabiting
the
human
intestines,
potentially
influencing
both
physiological
and
pathophysiological
processes
in
body.
Existing
evidence
suggests
that
nutrients
can
influence
modulation
gut
microbiota.
However,
there
still
limited
regarding
effects
vitamin
mineral
supplementation
on
through
epigenetic
modification.
It
plausible
maintaining
an
adequate
dietary
intake
D,
iron,
fibre,
zinc
magnesium
may
have
beneficial
effect
alleviating
inflammation
body,
reducing
oxidative
stress,
improving
condition
various
mechanisms.
Moreover,
epigenetics
involves
alterations
phenotype
cell
without
changing
its
fundamental
DNA
sequence.
appears
by
lead
to
regulation.
correlations
between
are
interdependent.
Therefore,
primary
objective
this
review
identify
complex
relationships
diet,
microbiota,
These
interactions
could
play
crucial
role
systemic
health.
Molecular and Cellular Endocrinology,
Год журнала:
2022,
Номер
546, С. 111572 - 111572
Опубликована: Янв. 20, 2022
The
role
of
the
intestinal
microbiota
as
a
regulator
gut-brain
axis
signalling
has
risen
to
prominence
in
recent
years.
Understanding
relationship
between
gut
microbiota,
metabolites
it
produces,
and
brain
will
be
critical
for
subsequent
development
new
therapeutic
approaches,
including
identification
novel
psychobiotics.
A
key
focus
this
regard
have
been
short-chain
fatty
acids
(SCFAs)
produced
by
bacterial
fermentation
dietary
fibre,
which
include
butyrate,
acetate,
propionate.
Ongoing
research
is
focused
on
entry
SCFAs
into
systemic
circulation
from
lumen,
their
migration
cerebral
across
blood
barrier,
potential
exert
acute
chronic
effects
structure
function.
This
review
aims
discuss
our
current
mechanistic
understanding
direct
indirect
influence
that
function,
behaviour
physiology,
inform
future
microbiota-targeted
interventions
disorders.
World Journal of Gastroenterology,
Год журнала:
2022,
Номер
28(30), С. 4053 - 4060
Опубликована: Авг. 9, 2022
The
gut
microbiota
is
a
complex
community
of
microorganisms
that
inhabit
the
digestive
tracts
humans,
living
in
symbiosis
with
host.
Dysbiosis,
characterized
by
an
imbalance
between
beneficial
and
opportunistic
microbiota,
associated
several
gastrointestinal
disorders,
such
as
irritable
bowel
syndrome
(IBS);
inflammatory
disease
(IBD),
represented
ulcerative
colitis
Crohn's
disease;
colorectal
cancer
(CRC).
Dysbiosis
can
disrupt
mucosal
barrier,
resulting
perpetuation
inflammation
carcinogenesis.
increase
some
specific
groups
harmful
bacteria,
Escherichia
coli
(E.
coli)
enterotoxigenic
Bacteroides
fragilis
(ETBF),
has
been
chronic
tissue
release
pro-inflammatory
carcinogenic
mediators,
increasing
chance
developing
CRC,
following
inflammation-dysplasia-cancer
sequence
IBD
patients.
Therefore,
aim
present
review
was
to
analyze
correlation
changes
development
maintenance
IBD,
IBD-associated
CRC.
Patients
CRC
have
shown
reduced
bacterial
diversity
abundance
compared
healthy
individuals,
enrichment
Firmicute
sand
Bacteroidetes.
Specific
bacteria
are
also
onset
progression
Fusobacterium
nucleatum,
E.
coli,
Enterococcus
faecalis,
Streptococcus
gallolyticus,
ETBF.
Future
research
evaluate
advantages
modulating
preventive
measures
high-risk
patients,
directly
affecting
prognosis
quality
life
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Июль 22, 2021
Intestinal
microbiota
dysbiosis
is
an
established
characteristic
of
ulcerative
colitis
(UC).
Regulating
the
gut
attractive
alternative
UC
treatment
strategy,
considering
potential
adverse
effects
synthetic
drugs
used
to
treat
UC.
Kaempferol
(Kae)
anti-inflammatory
and
antioxidant
flavonoid
derived
from
a
variety
medicinal
plants.
In
this
study,
we
determined
efficacy
mechanism
action
Kae
as
anti-UC
agent
in
dextran
sulfate
sodium
(DSS)-induced
mice.
DSS
challenge
mouse
model
led
weight
loss,
diarrhea
accompanied
by
mucous
blood,
histological
abnormalities,
shortening
colon,
all
which
were
significantly
alleviated
pretreatment
with
Kae.
addition,
intestinal
permeability
was
shown
improve
using
fluorescein
isothiocyanate
(FITC)-dextran
administration.
DSS-induced
destruction
barrier
also
prevented
administration
via
increases
levels
ZO-1,
occludin,
claudin-1.
Furthermore,
decreased
IL-1β,
IL-6,
TNF-α
downregulated
transcription
array
inflammatory
signaling
molecules,
while
it
increased
IL-10
mRNA
expression.
Notably,
reshaped
microbiome
elevating
Firmicutes
Bacteroidetes
ratio;
increasing
linear
discriminant
analysis
scores
beneficial
bacteria,
such
Prevotellaceae
Ruminococcaceae;
reducing
richness
Proteobacteria
DSS-challenged
There
evident
shift
profile
fecal
metabolites
group.
Serum
LPS
downstream
TLR4-NF-κB
supplementation.
Moreover,
transplantation
Kae-treated
mice
confirmed
on
modulating
alleviate
Therefore,
may
exert
protective
against
through
regulating
TLR4-related
pathways.
This
study
demonstrates
its
therapeutic
mechanisms,
offers
novel
insights
into
prevention
diseases
natural
products.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Май 25, 2023
Abstract
Obstructive
sleep
apnea
syndrome
(OSAS)
is
a
common
breathing
disorder
in
which
the
airways
narrow
or
collapse
during
sleep,
causing
obstructive
apnea.
The
prevalence
of
OSAS
continues
to
rise
worldwide,
particularly
middle-aged
and
elderly
individuals.
mechanism
upper
airway
incompletely
understood
but
associated
with
several
factors,
including
obesity,
craniofacial
changes,
altered
muscle
function
airway,
pharyngeal
neuropathy,
fluid
shifts
neck.
main
characteristics
are
recurrent
pauses
respiration,
lead
intermittent
hypoxia
(IH)
hypercapnia,
accompanied
by
blood
oxygen
desaturation
arousal
sharply
increases
risk
diseases.
This
paper
first
briefly
describes
epidemiology,
incidence,
pathophysiological
mechanisms
OSAS.
Next,
alterations
relevant
signaling
pathways
induced
IH
systematically
reviewed
discussed.
For
example,
can
induce
gut
microbiota
(GM)
dysbiosis,
impair
intestinal
barrier,
alter
metabolites.
These
ultimately
secondary
oxidative
stress,
systemic
inflammation,
sympathetic
activation.
We
then
summarize
effects
on
disease
pathogenesis,
cardiocerebrovascular
disorders,
neurological
metabolic
diseases,
cancer,
reproductive
COVID-19.
Finally,
different
therapeutic
strategies
for
caused
causes
proposed.
Multidisciplinary
approaches
shared
decision-making
necessary
successful
treatment
future,
more
randomized
controlled
trials
needed
further
evaluation
define
what
treatments
best
specific
patients.
The
gut
microbiota
and
its
homeostasis
play
a
crucial
role
in
human
health.
However,
for
some
diseases
related
to
the
microbiota,
current
traditional
medicines
can
only
relieve
symptoms,
it
is
difficult
solve
root
causes
or
even
cause
side
effects
like
disturbances
microbiota.
Increasing
clinical
studies
evidences
have
demonstrated
that
probiotics,
prebiotics,
postbiotics
prevent
treat
various
diseases,
but
currently
they
be
used
as
dietary
supplements
rather
than
medicines,
which
restricts
application
of
probiotics
field
medicine.
Here,
this
review
analyzes
importance
health
problems
systematically
summarizes
effectiveness
mechanisms
maintaining
treating
based
on
animal
models
trials.
And
research
outcomes
development
trends
field,
challenges
prospects
their
health,
alleviating
are
analyzed.
It
hoped
promote
disease
treatment
open
up
new
frontiers
probiotic
research.
Biomedicines,
Год журнала:
2023,
Номер
11(2), С. 294 - 294
Опубликована: Янв. 20, 2023
Gut
microbes
and
their
metabolites
are
actively
involved
in
the
development
regulation
of
host
immunity,
which
can
influence
disease
susceptibility.
Herein,
we
review
most
recent
research
advancements
gut
microbiota–immune
axis.
We
discuss
detail
how
microbiota
is
a
tipping
point
for
neonatal
immune
as
indicated
by
newly
uncovered
phenomenon,
such
maternal
imprinting,
utero
intestinal
metabolome,
weaning
reaction.
describe
shapes
both
innate
adaptive
immunity
with
emphasis
on
short-chain
fatty
acids
secondary
bile
acids.
also
comprehensively
delineate
disruption
axis
results
immune-mediated
diseases,
gastrointestinal
infections,
inflammatory
bowel
cardiometabolic
disorders
(e.g.,
cardiovascular
diabetes,
hypertension),
autoimmunity
rheumatoid
arthritis),
hypersensitivity
asthma
allergies),
psychological
anxiety),
cancer
colorectal
hepatic).
further
encompass
role
fecal
transplantation,
probiotics,
prebiotics,
dietary
polyphenols
reshaping
therapeutic
potential.
Continuing,
examine
modulates
therapies,
including
checkpoint
inhibitors,
JAK
anti-TNF
therapies.
lastly
mention
current
challenges
metagenomics,
germ-free
models,
recapitulation
to
achieve
fundamental
understanding
regulates
immunity.
Altogether,
this
proposes
improving
immunotherapy
efficacy
from
perspective
microbiome-targeted
interventions.
Journal of sport and health science/Journal of Sport and Health Science,
Год журнала:
2022,
Номер
12(1), С. 8 - 35
Опубликована: Окт. 29, 2022
Exercise
has
long
been
known
for
its
active
role
in
improving
physical
fitness
and
sustaining
health.
Regular
moderate-intensity
exercise
improves
all
aspects
of
human
health
is
widely
accepted
as
a
preventative
therapeutic
strategy
various
diseases.
It
well-documented
that
maintains
restores
homeostasis
at
the
organismal,
tissue,
cellular,
molecular
levels
to
stimulate
positive
physiological
adaptations
consequently
protect
against
pathological
conditions.
Here
we
mainly
summarize
how
affects
major
hallmarks
health,
including
integrity
barriers,
containment
local
perturbations,
recycling
turnover,
integration
circuitries,
rhythmic
oscillations,
homeostatic
resilience,
hormetic
regulation,
well
repair
regeneration.
Furthermore,
current
understanding
mechanisms
responsible
beneficial
response
exercise.
This
review
aimed
providing
comprehensive
summary
vital
biological
through
which
opens
window
application
other
interventions.
We
hope
continuing
investigation
this
field
will
further
increase
our
processes
involved
thus
get
us
closer
identification
new
therapeutics
improve
quality
life.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(15), С. 8343 - 8343
Опубликована: Июль 28, 2022
The
digestive
tract
is
replete
with
complex
and
diverse
microbial
communities
that
are
important
for
the
regulation
of
multiple
pathophysiological
processes
in
humans
animals,
particularly
those
involved
maintenance
intestinal
homeostasis,
immunity,
inflammation,
tumorigenesis.
diversity
bile
acids
a
result
joint
efforts
host
microflora.
There
bidirectional
relationship
between
community
that,
while
flora
tightly
modulates
metabolism
synthesis
acids,
acid
pool
composition
affect
homeostasis
flora.
Homeostatic
imbalances
systems
may
lead
to
development
variety
diseases,
such
as
inflammatory
bowel
disease
(IBD),
colorectal
cancer
(CRC),
hepatocellular
carcinoma
(HCC),
type
2
diabetes
(T2DM),
polycystic
ovary
syndrome
(PCOS).
interactions
be
(in)directly
pathogenesis
these
diseases.
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
14
Опубликована: Фев. 7, 2023
Morbidity
and
mortality
of
cardiovascular
diseases
(CVDs)
are
exceedingly
high
worldwide.
Researchers
have
found
that
the
occurrence
development
CVDs
closely
related
to
intestinal
microecology.
Imbalances
in
microecology
caused
by
changes
composition
microbiota
will
eventually
alter
metabolites,
thus
transforming
host
physiological
state
from
healthy
mode
pathological
mode.
Trimethylamine
N-oxide
(TMAO)
is
produced
metabolism
dietary
choline
L-carnitine
microbiota,
many
studies
shown
this
important
product
inhibits
cholesterol
metabolism,
induces
platelet
aggregation
thrombosis,
promotes
atherosclerosis.
TMAO
directly
or
indirectly
involved
pathogenesis
an
risk
factor
affecting
even
prognosis
CVDs.
This
review
presents
biological
chemical
characteristics
TMAO,
process
gut
microbiota.
In
particular,
focuses
on
summarizing
how
increase
microbial
metabolite
affects
including
atherosclerosis,
heart
failure,
hypertension,
arrhythmia,
coronary
artery
disease,
other
CVD-related
diseases.
Understanding
mechanism
increases
potentially
facilitate
identification
targeted
therapy
for